# ALEVE PM
> **NDA205352** · New Drug Application · Sponsor: BAYER HLTHCARE · Approved 2014-01-17
## Drug
- **FDA Application Number:** NDA205352
- **Application type:** New Drug Application
- **Brand name:** ALEVE PM
- **Generic name:** DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM
- **Active ingredients:** DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** BAYER HLTHCARE
- **Manufacturer:** Bayer HealthCare LLC.
- **First approval:** 2014-01-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205352)
---
*AI Analytics · CC0 1.0*